Intrinsiqq
Staar Surgical Company logo

Staar Surgical Company Quality Score

STAA

Compare
Quality34

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
40/100
2422.0x

Above 30x, priced for sustained outperformance

Cash Flow Multiple
40/100
68.1x

Above 30x, cash flow yield is thin

Revenue Growth
70/100
8.2%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
0/100
0.3%

Below 2%, essentially flat

Business Quality & Capital Allocation

Share Dilution
30/100
4.2%

Diluting 2–5%, watch for SBC

Margin Trend
0/100
-18.1pp

Contracted >2pp, margin pressure

Capital Structure
100/100
-$173M

Net cash position, no leverage concern

2022
$212M
$31.0M
2023
$221M
$36.0M
2024
$230M
$39.0M
2026
$188M
$38.0M
TTM
$206M
$34.0M
CashDebt
Return on Capital
0/100
0.1%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Staar Surgical (STAA) quality: score, margins and returns

Staar Surgical (STAA) scores 34/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 8 metrics each scored 0 to 100, on 0.2% operating margins and 0.1% ROIC. Every metric is computed from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Staar Surgical (STAA) a high-quality business?+

Staar Surgical scores 34 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a 0.2% operating margin and a 0.1% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Staar Surgical's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from STAA's SEC filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Staar Surgical scores well and where it falls behind.

What is Staar Surgical's return on invested capital (ROIC)?+

Staar Surgical earns about 0.1% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to STAA's margins and growth on this scorecard to judge durability.

How profitable is Staar Surgical?+

Staar Surgical runs an operating margin of about 0.2% and a net margin of about 0.2%. Revenue has grown at roughly 7.9% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from SEC filings, not investment advice.

How the market compares: US profitability statistics

SourceQuality score computed from the 10-Q filed 30 Oct 2026, covering the period ending 2 Oct 2026, as reported to the SEC. Data last refreshed 5 Nov 2026. How this is calculated.

Fiscal year ends Jan. Sector medians are approximate S&P 500 benchmarks and update periodically. Checks use broad-market heuristics, so sector norms may differ, and the valuation checks are more cyclical than the quality checks.

Peers

Ophthalmic Goods · Pick stocks to compare with STAA

CompareIntrinsic value
RXSTRxSight Inc.
$4.47-3.04%63
WRBYWarby Parker Inc.
$23.12-4.19%65
EYENational Vision Holdings Inc.
$16.72-1.70%69
ANGOAngiodynamics Inc.
$10.81+0.46%40
PRCTProcept BioRobotics Corporation
$24.70-4.08%40
MDXGMiMedx Group, Inc.
$3.05-1.93%18
INGNInogen Inc.
$5.30-2.21%25
TCMDTactile Systems Technology Inc.
$25.60-1.50%74

Held by ETFs

STAA is in 35 US ETFs. The largest of them, with STAA's weight in each:

Spot a number that looks wrong? Check it in STAA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing STAA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.